Showing results (1071-1080 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|June 7, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trialB R Luce, J W Singer, J M Weschler, et al.Pharmacoeconomics|October 5, 1995
Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarctionL B Barradell, K L GoaPharmacoeconomics|December 8, 1997
Peripheral arterial obliterative disease. Cost of illness in FranceA Montron, E Guignard, A Pelc, et al.Pharmacoeconomics|December 8, 1997
Using pharmacoeconomic analysis to make drug insurance coverage decisionsA H Anis, T Rahman, M T SchechterPharmacoeconomics|June 6, 1998
The use of decision-analytical modelling in economic evaluation of patch testing in allergic contact dermatitisR Rajagopalan, R T Anderson, S Sarma, et al.Pharmacoeconomics|July 6, 1998
Reporting format for economic evaluation. Part I: Application to the Dutch healthcare systemM J Nuijten, M J Brorens, Y A Hekster, et al.Pharmacoeconomics|July 6, 1998
Quality of life following a change in therapy for diabetes mellitusM Pibernik-Okanović, S Szabo, Z MetelkoPharmacoeconomics|July 6, 1998
Cost effectiveness of screening for subclinical hypothyroidism in the elderly. A decision-analytical modelM Bona, F Santini, G Rivolta, et al.Pharmacoeconomics|August 5, 1998
Reporting format for economic evaluation. Part II: Focus on modelling studiesM J Nuijten, M H Pronk, M J Brorens, et al.Pharmacoeconomics|August 5, 1998
Cost effectiveness of immunoprophylaxis in the prevention of recurrent infectious rhinitis in adultsG Berdeaux, A Lafuma, A M Perruchet, et al.Pageof 336